PRJNA195909:zebrafish embryo and larva development
Gene Symbol | Gene ID | Gene Info |
---|---|---|
tbp
|
ENSDARG00000014994 | TATA box binding protein |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
tbp | dr11_v1_chr13_-_24396003_24396003 | -0.93 | 2.9e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_22240052 | 24.81 |
ENSDART00000111109
|
crygm2d9
|
crystallin, gamma M2d9 |
chr9_-_22232902 | 24.34 |
ENSDART00000101845
|
crygm2d5
|
crystallin, gamma M2d5 |
chr3_-_32818607 | 20.16 |
ENSDART00000075465
|
mylpfa
|
myosin light chain, phosphorylatable, fast skeletal muscle a |
chr9_-_22245572 | 19.25 |
ENSDART00000114943
|
crygm2d4
|
crystallin, gamma M2d4 |
chr9_-_22158784 | 19.12 |
ENSDART00000167850
|
crygm2d14
|
crystallin, gamma M2d14 |
chr9_-_22299412 | 18.76 |
ENSDART00000139101
|
crygm2d21
|
crystallin, gamma M2d21 |
chr9_-_22281854 | 18.07 |
ENSDART00000146319
|
crygm2d3
|
crystallin, gamma M2d3 |
chr9_-_22213297 | 18.00 |
ENSDART00000110656
ENSDART00000133149 |
crygm2d20
|
crystallin, gamma M2d20 |
chr9_-_22135576 | 17.12 |
ENSDART00000101902
|
crygm2d8
|
crystallin, gamma M2d8 |
chr12_-_17712393 | 16.44 |
ENSDART00000143534
ENSDART00000010144 |
pvalb2
|
parvalbumin 2 |
chr5_+_37978501 | 16.40 |
ENSDART00000012050
|
apoa1a
|
apolipoprotein A-Ia |
chr5_-_32274383 | 15.49 |
ENSDART00000122889
|
myhz1.3
|
myosin, heavy polypeptide 1.3, skeletal muscle |
chr9_-_22135420 | 15.03 |
ENSDART00000184959
|
crygm2d8
|
crystallin, gamma M2d8 |
chr3_-_55121125 | 14.87 |
ENSDART00000125092
|
hbae1
|
hemoglobin, alpha embryonic 1 |
chr19_-_5345930 | 14.81 |
ENSDART00000066620
ENSDART00000151398 |
krtt1c19e
|
keratin type 1 c19e |
chr9_-_22129788 | 14.55 |
ENSDART00000124272
ENSDART00000175417 |
crygm2d8
|
crystallin, gamma M2d8 |
chr9_-_22117430 | 14.35 |
ENSDART00000101916
|
crygm2d15
|
crystallin, gamma M2d15 |
chr24_-_41312459 | 14.21 |
ENSDART00000041349
|
crygn2
|
crystallin, gamma N2 |
chr9_-_22318511 | 14.17 |
ENSDART00000129295
|
crygm2d2
|
crystallin, gamma M2d2 |
chr2_+_16780643 | 13.89 |
ENSDART00000125647
ENSDART00000108611 ENSDART00000181245 ENSDART00000163194 |
tfa
|
transferrin-a |
chr9_-_22272181 | 13.69 |
ENSDART00000113174
|
crygm2d7
|
crystallin, gamma M2d7 |
chr10_-_44027391 | 13.39 |
ENSDART00000145404
|
crybb1
|
crystallin, beta B1 |
chr16_-_45917322 | 13.17 |
ENSDART00000060822
|
afp4
|
antifreeze protein type IV |
chr9_-_22182396 | 12.98 |
ENSDART00000101809
|
crygm2d6
|
crystallin, gamma M2d6 |
chr18_-_46010 | 12.73 |
ENSDART00000052641
|
gatm
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr2_+_16781015 | 12.49 |
ENSDART00000155147
ENSDART00000003845 |
tfa
|
transferrin-a |
chr9_-_22158325 | 12.27 |
ENSDART00000114568
|
crygm2d16
|
crystallin, gamma M2d16 |
chr5_-_36837846 | 12.26 |
ENSDART00000032481
|
ckma
|
creatine kinase, muscle a |
chr5_-_71722257 | 12.18 |
ENSDART00000013404
|
ak1
|
adenylate kinase 1 |
chr5_-_30615901 | 12.18 |
ENSDART00000147769
|
si:ch211-117m20.5
|
si:ch211-117m20.5 |
chr8_+_6863462 | 11.15 |
ENSDART00000064163
|
nefmb
|
neurofilament, medium polypeptide b |
chr9_-_22188117 | 11.08 |
ENSDART00000132890
|
crygm2d17
|
crystallin, gamma M2d17 |
chr8_+_999421 | 10.72 |
ENSDART00000149528
|
fabp1b.1
|
fatty acid binding protein 1b, tandem duplicate 1 |
chr5_+_4366431 | 10.38 |
ENSDART00000168560
ENSDART00000149185 |
sat1a.2
|
spermidine/spermine N1-acetyltransferase 1a, duplicate 2 |
chr9_-_22339582 | 10.19 |
ENSDART00000134805
|
crygm2d1
|
crystallin, gamma M2d1 |
chr8_+_26818446 | 10.06 |
ENSDART00000134987
ENSDART00000138835 |
si:ch211-156j16.1
|
si:ch211-156j16.1 |
chr16_-_45917683 | 10.03 |
ENSDART00000184289
|
afp4
|
antifreeze protein type IV |
chr3_-_31804481 | 10.00 |
ENSDART00000028270
|
gfap
|
glial fibrillary acidic protein |
chr7_+_29951997 | 9.99 |
ENSDART00000173453
|
tpma
|
alpha-tropomyosin |
chr24_+_32176155 | 9.33 |
ENSDART00000003745
|
vim
|
vimentin |
chr20_-_9980318 | 9.27 |
ENSDART00000080664
|
ACTC1
|
zgc:86709 |
chr9_-_22147567 | 8.63 |
ENSDART00000110941
|
crygm2d14
|
crystallin, gamma M2d14 |
chr3_+_15505275 | 8.40 |
ENSDART00000141714
|
nupr1
|
nuclear protein 1 |
chr9_+_22080122 | 8.39 |
ENSDART00000065956
ENSDART00000136014 |
crygm2e
|
crystallin, gamma M2e |
chr8_+_48613040 | 8.32 |
ENSDART00000121432
|
nppa
|
natriuretic peptide A |
chr5_-_25583125 | 8.27 |
ENSDART00000031665
ENSDART00000145353 |
anxa1a
|
annexin A1a |
chr24_+_3307857 | 8.14 |
ENSDART00000106527
|
gyg1b
|
glycogenin 1b |
chr9_-_45602978 | 8.04 |
ENSDART00000139019
ENSDART00000085763 |
agr1
|
anterior gradient 1 |
chr23_-_21446985 | 8.02 |
ENSDART00000044080
|
her12
|
hairy-related 12 |
chr12_-_35988586 | 7.88 |
ENSDART00000157746
|
pde6gb
|
phosphodiesterase 6G, cGMP-specific, rod, gamma, paralog b |
chr6_+_35362225 | 7.63 |
ENSDART00000133783
ENSDART00000102483 |
rgs4
|
regulator of G protein signaling 4 |
chr5_-_67911111 | 7.61 |
ENSDART00000051833
|
gsx1
|
GS homeobox 1 |
chr21_+_20383837 | 7.60 |
ENSDART00000026430
|
hspb11
|
heat shock protein, alpha-crystallin-related, b11 |
chr15_-_5815006 | 7.54 |
ENSDART00000102459
|
rbp2a
|
retinol binding protein 2a, cellular |
chr8_+_17078692 | 7.40 |
ENSDART00000023206
|
plk2b
|
polo-like kinase 2b (Drosophila) |
chr19_+_10845953 | 7.34 |
ENSDART00000157589
|
apoa4a
|
apolipoprotein A-IV a |
chr24_-_25691020 | 7.31 |
ENSDART00000015391
|
chrnd
|
cholinergic receptor, nicotinic, delta (muscle) |
chr23_+_27675581 | 7.30 |
ENSDART00000127198
|
rps26
|
ribosomal protein S26 |
chr11_+_34235372 | 7.28 |
ENSDART00000063150
|
fam43a
|
family with sequence similarity 43, member A |
chr2_-_38000276 | 7.21 |
ENSDART00000034790
|
pcp4l1
|
Purkinje cell protein 4 like 1 |
chr6_+_269204 | 7.17 |
ENSDART00000191678
|
atf4a
|
activating transcription factor 4a |
chr5_+_37837245 | 6.95 |
ENSDART00000171617
|
epd
|
ependymin |
chr5_-_64168415 | 6.86 |
ENSDART00000048395
|
cmlc1
|
cardiac myosin light chain-1 |
chr16_+_23960744 | 6.82 |
ENSDART00000058965
|
apoeb
|
apolipoprotein Eb |
chr1_+_29096881 | 6.65 |
ENSDART00000075539
|
cryaa
|
crystallin, alpha A |
chr21_+_7823146 | 6.61 |
ENSDART00000030579
|
crhbp
|
corticotropin releasing hormone binding protein |
chr9_+_23900703 | 6.60 |
ENSDART00000127859
|
trim63b
|
tripartite motif containing 63b |
chr16_+_23960933 | 6.58 |
ENSDART00000146077
|
apoeb
|
apolipoprotein Eb |
chr19_-_5332784 | 6.45 |
ENSDART00000010373
|
krt1-19d
|
keratin, type 1, gene 19d |
chr19_-_41069573 | 6.18 |
ENSDART00000111982
ENSDART00000193142 |
sgce
|
sarcoglycan, epsilon |
chr23_-_10177442 | 6.14 |
ENSDART00000144280
ENSDART00000129044 |
krt5
|
keratin 5 |
chr5_-_27867657 | 6.04 |
ENSDART00000112495
|
tcima
|
transcriptional and immune response regulator a |
chr7_-_31441420 | 6.02 |
ENSDART00000075398
|
cilp
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
chr19_+_24882845 | 5.97 |
ENSDART00000010580
|
si:ch211-195b13.1
|
si:ch211-195b13.1 |
chr3_+_33340939 | 5.94 |
ENSDART00000128786
|
pyya
|
peptide YYa |
chr23_+_45456490 | 5.92 |
ENSDART00000036631
|
cyr61
|
cysteine-rich, angiogenic inducer, 61 |
chr10_-_24371312 | 5.91 |
ENSDART00000149362
|
pitpnab
|
phosphatidylinositol transfer protein, alpha b |
chr5_+_9348284 | 5.88 |
ENSDART00000149417
|
tal2
|
T-cell acute lymphocytic leukemia 2 |
chr22_-_24248420 | 5.87 |
ENSDART00000165433
|
rgs2
|
regulator of G protein signaling 2 |
chr2_+_24536762 | 5.84 |
ENSDART00000144149
|
angptl4
|
angiopoietin-like 4 |
chr7_+_20524064 | 5.80 |
ENSDART00000052917
|
slc3a2a
|
solute carrier family 3 (amino acid transporter heavy chain), member 2a |
chr22_-_11626014 | 5.55 |
ENSDART00000063133
ENSDART00000160085 |
gcga
|
glucagon a |
chr2_-_30182353 | 5.54 |
ENSDART00000019149
|
rpl7
|
ribosomal protein L7 |
chr8_+_48609521 | 5.27 |
ENSDART00000060765
|
nppb
|
natriuretic peptide B |
chr1_+_55137943 | 5.23 |
ENSDART00000138070
ENSDART00000150510 ENSDART00000133472 ENSDART00000136378 |
mb
|
myoglobin |
chr10_-_7785930 | 5.21 |
ENSDART00000043961
ENSDART00000111058 |
mpx
|
myeloid-specific peroxidase |
chr6_+_41181869 | 5.16 |
ENSDART00000002046
|
opn1mw1
|
opsin 1 (cone pigments), medium-wave-sensitive, 1 |
chr15_+_28368823 | 5.08 |
ENSDART00000142298
|
slc43a2a
|
solute carrier family 43 (amino acid system L transporter), member 2a |
chr6_-_54180699 | 4.93 |
ENSDART00000045901
|
rps10
|
ribosomal protein S10 |
chr4_+_25706037 | 4.90 |
ENSDART00000141133
|
lamb1b
|
laminin, beta 1b |
chr14_+_45406299 | 4.89 |
ENSDART00000173142
ENSDART00000112377 |
map1lc3cl
|
microtubule-associated protein 1 light chain 3 gamma, like |
chr3_-_36606884 | 4.76 |
ENSDART00000172003
|
si:dkeyp-72e1.6
|
si:dkeyp-72e1.6 |
chr2_+_24507597 | 4.65 |
ENSDART00000133109
|
rps28
|
ribosomal protein S28 |
chr22_+_5752257 | 4.64 |
ENSDART00000143052
|
cox14
|
COX14 cytochrome c oxidase assembly factor |
chr18_-_26854959 | 4.59 |
ENSDART00000057553
|
ch25hl1.1
|
cholesterol 25-hydroxylase like 1, tandem duplicate 1 |
chr2_-_1443692 | 4.58 |
ENSDART00000004533
|
rpe65a
|
retinal pigment epithelium-specific protein 65a |
chr21_-_20341836 | 4.55 |
ENSDART00000176689
|
rbp4l
|
retinol binding protein 4, like |
chr25_+_8356707 | 4.55 |
ENSDART00000153708
|
muc5.1
|
mucin 5.1, oligomeric mucus/gel-forming |
chr6_-_53426773 | 4.53 |
ENSDART00000162791
|
mst1
|
macrophage stimulating 1 |
chr9_-_1703761 | 4.43 |
ENSDART00000144822
ENSDART00000137210 ENSDART00000135273 |
hnrnpa3
|
heterogeneous nuclear ribonucleoprotein A3 |
chr14_-_11430566 | 4.42 |
ENSDART00000137154
ENSDART00000091158 |
irg1l
|
immunoresponsive gene 1, like |
chr1_+_10683843 | 4.38 |
ENSDART00000054879
|
zgc:103678
|
zgc:103678 |
chr20_+_27020201 | 4.35 |
ENSDART00000126919
ENSDART00000016014 |
chga
|
chromogranin A |
chr2_+_55365727 | 4.34 |
ENSDART00000162943
|
FP245456.1
|
|
chr23_+_19813677 | 4.34 |
ENSDART00000139192
ENSDART00000142308 |
emd
|
emerin (Emery-Dreifuss muscular dystrophy) |
chr24_+_21621654 | 4.30 |
ENSDART00000002595
|
rpl21
|
ribosomal protein L21 |
chr1_-_22678471 | 4.15 |
ENSDART00000128918
|
fgfbp1b
|
fibroblast growth factor binding protein 1b |
chr14_-_28001986 | 4.12 |
ENSDART00000054115
|
tsc22d3
|
TSC22 domain family, member 3 |
chr13_+_25455319 | 4.12 |
ENSDART00000145948
|
pkd2l1
|
polycystic kidney disease 2-like 1 |
chr2_+_24507770 | 4.11 |
ENSDART00000154802
ENSDART00000052063 |
rps28
|
ribosomal protein S28 |
chr21_-_28523548 | 4.11 |
ENSDART00000077910
|
epdl2
|
ependymin-like 2 |
chr17_-_37214196 | 3.93 |
ENSDART00000128715
|
kif3cb
|
kinesin family member 3Cb |
chr12_+_39034541 | 3.90 |
ENSDART00000182502
ENSDART00000169813 |
si:dkey-239b22.2
|
si:dkey-239b22.2 |
chr15_+_19682013 | 3.86 |
ENSDART00000127368
|
si:dkey-4p15.5
|
si:dkey-4p15.5 |
chr6_-_346084 | 3.82 |
ENSDART00000162599
|
pde6ha
|
phosphodiesterase 6H, cGMP-specific, cone, gamma, paralog a |
chr11_+_3575963 | 3.76 |
ENSDART00000077305
|
si:dkey-33m11.8
|
si:dkey-33m11.8 |
chr23_+_25305431 | 3.74 |
ENSDART00000143291
|
RPL41
|
si:dkey-151g10.6 |
chr20_-_22464250 | 3.73 |
ENSDART00000165904
|
pdgfra
|
platelet-derived growth factor receptor, alpha polypeptide |
chr7_+_57795974 | 3.70 |
ENSDART00000148369
|
camk2d1
|
calcium/calmodulin-dependent protein kinase (CaM kinase) II delta 1 |
chr11_+_25477643 | 3.62 |
ENSDART00000065941
|
opn1lw1
|
opsin 1 (cone pigments), long-wave-sensitive, 1 |
chr22_+_16497670 | 3.61 |
ENSDART00000014330
|
ier5
|
immediate early response 5 |
chr13_+_35745572 | 3.59 |
ENSDART00000159690
|
gpr75
|
G protein-coupled receptor 75 |
chr21_-_20342096 | 3.59 |
ENSDART00000065659
|
rbp4l
|
retinol binding protein 4, like |
chr23_+_18103080 | 3.56 |
ENSDART00000010270
|
mfsd4ab
|
major facilitator superfamily domain containing 4Ab |
chr11_+_15613218 | 3.54 |
ENSDART00000066033
|
gdf11
|
growth differentiation factor 11 |
chr11_-_6970107 | 3.52 |
ENSDART00000171255
|
COMP
|
si:ch211-43f4.1 |
chr19_+_19976990 | 3.51 |
ENSDART00000052627
|
npvf
|
neuropeptide VF precursor |
chr19_-_3167729 | 3.50 |
ENSDART00000110763
ENSDART00000145710 ENSDART00000074620 ENSDART00000105174 |
stm
|
starmaker |
chr8_-_22965214 | 3.46 |
ENSDART00000148178
|
emilin3a
|
elastin microfibril interfacer 3a |
chr6_+_39499623 | 3.44 |
ENSDART00000036057
|
si:ch211-173n18.3
|
si:ch211-173n18.3 |
chr4_+_842010 | 3.41 |
ENSDART00000067461
|
si:ch211-152c2.3
|
si:ch211-152c2.3 |
chr12_-_29624638 | 3.40 |
ENSDART00000126744
|
nrg3b
|
neuregulin 3b |
chr22_-_21392748 | 3.37 |
ENSDART00000144648
|
ankrd24
|
ankyrin repeat domain 24 |
chr7_-_35083184 | 3.37 |
ENSDART00000100253
ENSDART00000135250 ENSDART00000173511 |
agrp
|
agouti related neuropeptide |
chr10_+_15777258 | 3.33 |
ENSDART00000140511
|
apba1b
|
amyloid beta (A4) precursor protein-binding, family A, member 1b |
chr10_+_38593645 | 3.30 |
ENSDART00000011573
|
mmp13a
|
matrix metallopeptidase 13a |
chr10_-_6775271 | 3.28 |
ENSDART00000110735
|
zgc:194281
|
zgc:194281 |
chr11_-_3334248 | 3.27 |
ENSDART00000154314
ENSDART00000121861 |
prph
|
peripherin |
chr1_+_56447107 | 3.23 |
ENSDART00000091924
|
CABZ01059392.1
|
|
chr7_+_8456999 | 3.20 |
ENSDART00000172880
|
jac4
|
jacalin 4 |
chr19_-_42557416 | 3.17 |
ENSDART00000163217
ENSDART00000128278 ENSDART00000162304 ENSDART00000166556 |
si:dkey-267n13.1
|
si:dkey-267n13.1 |
chr25_-_34632050 | 3.15 |
ENSDART00000170671
|
megf8
|
multiple EGF-like-domains 8 |
chr9_-_32753535 | 3.06 |
ENSDART00000060006
|
olig2
|
oligodendrocyte lineage transcription factor 2 |
chr15_+_45643787 | 3.02 |
ENSDART00000055995
ENSDART00000157750 |
sagb
|
S-antigen; retina and pineal gland (arrestin) b |
chr19_-_3193912 | 3.01 |
ENSDART00000133159
|
si:ch211-133n4.6
|
si:ch211-133n4.6 |
chr12_+_48204891 | 3.01 |
ENSDART00000190534
ENSDART00000164427 |
ndr2
|
nodal-related 2 |
chr13_+_23176330 | 3.01 |
ENSDART00000168351
|
sorbs1
|
sorbin and SH3 domain containing 1 |
chr18_+_30507839 | 2.98 |
ENSDART00000026866
|
cox4i1
|
cytochrome c oxidase subunit IV isoform 1 |
chr23_+_26979174 | 2.95 |
ENSDART00000018654
|
rnd1b
|
Rho family GTPase 1b |
chr7_-_35083585 | 2.95 |
ENSDART00000192732
|
agrp
|
agouti related neuropeptide |
chr12_-_19346678 | 2.93 |
ENSDART00000044860
|
maff
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr10_-_44924289 | 2.92 |
ENSDART00000171267
|
tuba7l
|
tubulin, alpha 7 like |
chr25_+_30298377 | 2.92 |
ENSDART00000153622
|
C11orf96
|
chromosome 11 open reading frame 96 |
chr11_-_27702778 | 2.90 |
ENSDART00000045942
ENSDART00000125352 |
phf2
|
PHD finger protein 2 |
chr1_-_22338521 | 2.89 |
ENSDART00000176849
|
si:ch73-380n15.2
|
si:ch73-380n15.2 |
chr23_+_43950674 | 2.88 |
ENSDART00000167813
|
corin
|
corin, serine peptidase |
chr11_-_39202915 | 2.88 |
ENSDART00000105133
|
wnt4a
|
wingless-type MMTV integration site family, member 4a |
chr14_-_33334065 | 2.87 |
ENSDART00000052761
|
rpl39
|
ribosomal protein L39 |
chr3_+_59051503 | 2.83 |
ENSDART00000160767
|
rasd4
|
rasd family member 4 |
chr16_-_7228276 | 2.82 |
ENSDART00000149030
|
nt5c3a
|
5'-nucleotidase, cytosolic IIIA |
chr5_-_33259079 | 2.81 |
ENSDART00000132223
|
ifitm1
|
interferon induced transmembrane protein 1 |
chr21_+_43669943 | 2.79 |
ENSDART00000136025
|
tmlhe
|
trimethyllysine hydroxylase, epsilon |
chr13_-_20381485 | 2.77 |
ENSDART00000131351
|
si:ch211-270n8.1
|
si:ch211-270n8.1 |
chr10_-_5058823 | 2.72 |
ENSDART00000139825
|
tmem150c
|
transmembrane protein 150C |
chr13_-_2215213 | 2.71 |
ENSDART00000129773
|
mlip
|
muscular LMNA-interacting protein |
chr20_-_53981626 | 2.68 |
ENSDART00000023550
|
hsp90aa1.2
|
heat shock protein 90, alpha (cytosolic), class A member 1, tandem duplicate 2 |
chr3_-_60401826 | 2.67 |
ENSDART00000144030
ENSDART00000160821 |
si:ch211-214b16.4
|
si:ch211-214b16.4 |
chr8_-_6877390 | 2.65 |
ENSDART00000170883
ENSDART00000005321 |
neflb
|
neurofilament, light polypeptide b |
chr10_+_17776981 | 2.64 |
ENSDART00000141693
|
ccl19b
|
chemokine (C-C motif) ligand 19b |
chr20_+_42668875 | 2.62 |
ENSDART00000048890
|
slc22a2
|
solute carrier family 22 (organic cation transporter), member 2 |
chr10_-_22845485 | 2.60 |
ENSDART00000079454
|
vamp2
|
vesicle-associated membrane protein 2 |
chr10_+_42374957 | 2.59 |
ENSDART00000147926
|
COX5B
|
zgc:86599 |
chr4_+_75314247 | 2.58 |
ENSDART00000162365
|
CABZ01041913.1
|
|
chr20_-_33976937 | 2.58 |
ENSDART00000136834
|
sele
|
selectin E |
chr10_-_37075361 | 2.55 |
ENSDART00000132023
|
myo18aa
|
myosin XVIIIAa |
chr3_+_5575313 | 2.55 |
ENSDART00000134693
ENSDART00000101807 |
si:ch211-106h11.3
|
si:ch211-106h11.3 |
chr10_-_43964028 | 2.51 |
ENSDART00000009134
ENSDART00000133450 |
sept5b
|
septin 5b |
chr2_+_43920461 | 2.47 |
ENSDART00000123673
|
si:ch211-195h23.3
|
si:ch211-195h23.3 |
chr16_-_44349845 | 2.43 |
ENSDART00000170932
|
rims2a
|
regulating synaptic membrane exocytosis 2a |
chr3_-_57425961 | 2.39 |
ENSDART00000033716
|
socs3a
|
suppressor of cytokine signaling 3a |
chr22_-_20515347 | 2.38 |
ENSDART00000137371
|
atp8b3
|
ATPase phospholipid transporting 8B3 |
chr13_-_12645584 | 2.36 |
ENSDART00000176216
|
adh8b
|
alcohol dehydrogenase 8b |
chr11_+_42478184 | 2.34 |
ENSDART00000089963
|
zgc:110286
|
zgc:110286 |
chr10_+_17026870 | 2.33 |
ENSDART00000184529
ENSDART00000157480 |
CR855996.2
|
|
chr6_+_39493864 | 2.33 |
ENSDART00000086263
|
mettl7a
|
methyltransferase like 7A |
chr23_-_18913032 | 2.32 |
ENSDART00000136678
|
si:ch211-209j10.6
|
si:ch211-209j10.6 |
chr19_+_41769135 | 2.32 |
ENSDART00000087096
|
tinagl1
|
tubulointerstitial nephritis antigen-like 1 |
chr16_+_20161805 | 2.31 |
ENSDART00000192146
|
c16h2orf66
|
chromosome 16 C2orf66 homolog |
chr9_+_22017368 | 2.28 |
ENSDART00000023059
|
zgc:153846
|
zgc:153846 |
chr20_-_39273987 | 2.26 |
ENSDART00000127173
|
clu
|
clusterin |
chr2_-_7431590 | 2.24 |
ENSDART00000185699
|
asip2b
|
agouti signaling protein, nonagouti homolog (mouse) 2b |
chr24_-_37688398 | 2.22 |
ENSDART00000141414
|
zgc:112185
|
zgc:112185 |
chr13_-_15702672 | 2.20 |
ENSDART00000144445
ENSDART00000168950 |
ckba
|
creatine kinase, brain a |
chr24_-_5786759 | 2.18 |
ENSDART00000152069
|
chst2b
|
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2b |
chr11_+_6456146 | 2.17 |
ENSDART00000036939
|
gadd45ba
|
growth arrest and DNA-damage-inducible, beta a |
chr15_+_1134870 | 2.17 |
ENSDART00000155392
|
p2ry13
|
purinergic receptor P2Y13 |
chr13_+_35746440 | 2.15 |
ENSDART00000187859
|
gpr75
|
G protein-coupled receptor 75 |
chr6_-_49173891 | 2.14 |
ENSDART00000132867
|
ngfb
|
nerve growth factor b (beta polypeptide) |
chr3_-_58733718 | 2.13 |
ENSDART00000154603
|
si:ch73-281f12.4
|
si:ch73-281f12.4 |
chr22_-_9934854 | 2.12 |
ENSDART00000136404
|
si:dkey-253d23.11
|
si:dkey-253d23.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.6 | GO:1905072 | cardiac jelly development(GO:1905072) |
4.5 | 13.4 | GO:0071831 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) intermediate-density lipoprotein particle clearance(GO:0071831) |
4.2 | 12.7 | GO:0006601 | creatine metabolic process(GO:0006600) creatine biosynthetic process(GO:0006601) |
3.7 | 11.0 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) negative regulation of peptide hormone secretion(GO:0090278) |
3.3 | 16.4 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
2.6 | 10.4 | GO:0006598 | polyamine catabolic process(GO:0006598) putrescine catabolic process(GO:0009447) |
2.4 | 317.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
2.4 | 26.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
1.9 | 11.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
1.9 | 5.7 | GO:0060986 | regulation of endocrine process(GO:0044060) endocrine hormone secretion(GO:0060986) |
1.9 | 11.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.7 | 12.2 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.5 | 5.9 | GO:0090299 | regulation of neural crest formation(GO:0090299) |
1.4 | 8.3 | GO:0002825 | neutrophil apoptotic process(GO:0001781) regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) negative regulation of type 2 immune response(GO:0002829) inflammatory cell apoptotic process(GO:0006925) regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of phospholipase A2 activity(GO:0032429) interleukin-2 production(GO:0032623) regulation of interleukin-2 production(GO:0032663) positive regulation of interleukin-2 production(GO:0032743) myeloid cell apoptotic process(GO:0033028) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) regulation of myeloid cell apoptotic process(GO:0033032) positive regulation of myeloid cell apoptotic process(GO:0033034) T-helper 1 type immune response(GO:0042088) positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) T-helper 1 cell differentiation(GO:0045063) positive regulation of T-helper cell differentiation(GO:0045624) regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 1 cell differentiation(GO:0045627) regulation of T-helper 2 cell differentiation(GO:0045628) negative regulation of T-helper 2 cell differentiation(GO:0045629) positive regulation of fatty acid biosynthetic process(GO:0045723) positive regulation of alpha-beta T cell differentiation(GO:0046638) neutrophil clearance(GO:0097350) negative regulation of phospholipase A2 activity(GO:1900138) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.1 | 4.6 | GO:0016122 | tetraterpenoid metabolic process(GO:0016108) tetraterpenoid biosynthetic process(GO:0016109) carotenoid metabolic process(GO:0016116) carotenoid biosynthetic process(GO:0016117) xanthophyll metabolic process(GO:0016122) xanthophyll biosynthetic process(GO:0016123) zeaxanthin metabolic process(GO:1901825) zeaxanthin biosynthetic process(GO:1901827) |
1.1 | 6.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.1 | 14.5 | GO:0046314 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
1.0 | 4.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.0 | 2.9 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.9 | 6.3 | GO:2000253 | adult feeding behavior(GO:0008343) positive regulation of feeding behavior(GO:2000253) |
0.9 | 2.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.8 | 2.4 | GO:1903173 | fatty alcohol metabolic process(GO:1903173) |
0.8 | 3.1 | GO:0021742 | abducens nucleus development(GO:0021742) |
0.7 | 3.7 | GO:0003261 | cardiac muscle progenitor cell migration to the midline involved in heart field formation(GO:0003261) |
0.7 | 5.8 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.7 | 23.2 | GO:0060030 | dorsal convergence(GO:0060030) |
0.6 | 1.9 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) |
0.6 | 1.9 | GO:2000009 | regulation of protein localization to cell surface(GO:2000008) negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 13.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 4.4 | GO:0090594 | inflammatory response to wounding(GO:0090594) |
0.5 | 2.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.5 | 3.5 | GO:0045299 | otolith mineralization(GO:0045299) |
0.5 | 1.8 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.5 | 3.6 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 4.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 2.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.4 | 5.2 | GO:2000377 | regulation of reactive oxygen species metabolic process(GO:2000377) |
0.4 | 2.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.4 | 1.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 5.9 | GO:0007631 | feeding behavior(GO:0007631) |
0.3 | 1.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 2.4 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.3 | 1.9 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 1.4 | GO:0071380 | response to prostaglandin E(GO:0034695) cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 1.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 5.2 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 4.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 3.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 1.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 11.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 3.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 4.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.8 | GO:0007620 | copulation(GO:0007620) regulation of epinephrine secretion(GO:0014060) positive regulation of epinephrine secretion(GO:0032812) positive regulation of catecholamine secretion(GO:0033605) penile erection(GO:0043084) epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) positive regulation of amine transport(GO:0051954) regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) prolactin secretion(GO:0070459) |
0.2 | 1.0 | GO:0007508 | larval development(GO:0002164) larval heart development(GO:0007508) angiogenesis involved in wound healing(GO:0060055) |
0.2 | 1.4 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.2 | 5.6 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 1.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 5.9 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.2 | 2.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 6.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 2.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 4.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 2.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 1.9 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.2 | 0.9 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.2 | 17.4 | GO:0031101 | fin regeneration(GO:0031101) |
0.2 | 2.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 1.4 | GO:0006798 | polyphosphate metabolic process(GO:0006797) polyphosphate catabolic process(GO:0006798) |
0.2 | 3.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 1.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 2.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 3.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 4.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 5.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 2.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 2.6 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 1.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 4.9 | GO:1901214 | regulation of neuron death(GO:1901214) |
0.1 | 1.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 2.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 2.9 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 5.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 4.5 | GO:0030282 | bone mineralization(GO:0030282) |
0.1 | 1.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 3.3 | GO:0045103 | intermediate filament-based process(GO:0045103) intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 4.4 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 6.5 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 7.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 3.5 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 2.1 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.1 | 7.4 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 5.1 | GO:0097530 | granulocyte migration(GO:0097530) |
0.1 | 7.3 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.1 | 3.9 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.0 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) formaldehyde catabolic process(GO:0046294) |
0.0 | 4.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 1.9 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 2.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 2.7 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 3.7 | GO:0042060 | wound healing(GO:0042060) |
0.0 | 4.1 | GO:0033993 | response to lipid(GO:0033993) |
0.0 | 1.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.2 | GO:0046661 | male sex differentiation(GO:0046661) |
0.0 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.4 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 2.5 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 8.8 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter(GO:0045944) |
0.0 | 4.8 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 8.1 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 13.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.9 | 8.8 | GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane(GO:0098556) |
2.8 | 13.8 | GO:0005883 | neurofilament(GO:0005883) |
1.7 | 11.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.4 | 16.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 6.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.9 | 10.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 6.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 6.1 | GO:0045095 | keratin filament(GO:0045095) |
0.6 | 7.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.6 | 8.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 40.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.4 | 1.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.4 | 1.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 14.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.3 | 12.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 4.9 | GO:0005605 | basal lamina(GO:0005605) laminin complex(GO:0043256) |
0.2 | 12.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 18.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 2.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 2.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 18.6 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 4.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.5 | GO:0031105 | septin ring(GO:0005940) septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 2.4 | GO:0048788 | cytoskeleton of presynaptic active zone(GO:0048788) |
0.1 | 9.6 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 15.6 | GO:0005764 | lysosome(GO:0005764) |
0.0 | 58.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 13.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 3.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 26.8 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 4.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 3.3 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 1.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 1.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
3.9 | 313.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
3.3 | 16.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.7 | 8.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.5 | 10.4 | GO:0019809 | spermidine binding(GO:0019809) |
1.4 | 8.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.2 | 5.9 | GO:0031843 | neuropeptide Y receptor binding(GO:0031841) type 2 neuropeptide Y receptor binding(GO:0031843) |
1.2 | 8.1 | GO:0034632 | retinol transporter activity(GO:0034632) |
1.1 | 4.6 | GO:0052885 | retinol isomerase activity(GO:0050251) all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity(GO:0052885) |
1.1 | 14.5 | GO:0004111 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
1.0 | 7.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.0 | 2.9 | GO:0042165 | neurotransmitter binding(GO:0042165) acetylcholine binding(GO:0042166) |
0.9 | 12.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 3.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor binding(GO:0048407) |
0.9 | 11.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 5.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 10.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.7 | 4.9 | GO:0000254 | C-4 methylsterol oxidase activity(GO:0000254) |
0.7 | 2.7 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 2.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.5 | 2.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) S-(hydroxymethyl)glutathione dehydrogenase activity(GO:0051903) |
0.5 | 1.9 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.4 | 1.8 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.3 | GO:0070186 | growth hormone receptor binding(GO:0005131) growth hormone activity(GO:0070186) |
0.4 | 3.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 2.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 12.7 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.4 | 1.9 | GO:0031769 | glucagon receptor binding(GO:0031769) |
0.3 | 7.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.3 | 0.9 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 5.2 | GO:0019825 | oxygen transporter activity(GO:0005344) oxygen binding(GO:0019825) |
0.2 | 4.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 2.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 6.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 11.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 2.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.2 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.9 | GO:0005153 | interleukin-8 receptor binding(GO:0005153) |
0.2 | 3.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 3.6 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
0.2 | 1.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 14.4 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.2 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 2.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 6.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 6.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 33.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 2.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.2 | 2.1 | GO:0005165 | nerve growth factor receptor binding(GO:0005163) neurotrophin receptor binding(GO:0005165) |
0.1 | 1.9 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 3.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 2.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 7.4 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.4 | GO:0004309 | exopolyphosphatase activity(GO:0004309) |
0.1 | 51.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 5.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 5.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 1.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 22.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 3.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 3.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 2.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 3.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 2.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 2.1 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 59.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 4.8 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 2.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 2.9 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 2.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 10.5 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.0 | 6.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 4.3 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 2.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 1.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.4 | GO:0042805 | actinin binding(GO:0042805) muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
0.0 | 8.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 3.0 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 1.5 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 2.1 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 2.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 2.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 6.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 9.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 6.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 8.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 6.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 4.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 11.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 2.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.0 | 9.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 7.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 12.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 8.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 21.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 10.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 16.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 7.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 6.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 5.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 6.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 2.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 4.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 2.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 1.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |